Mr. Elizabeth Anne Bogen Whiteman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1109 Meade Ave, Prosser, WA 99350 Phone: 509-786-6626 |
Amy Rose Doherty Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Chardonnay Ave, Suite 1, Prosser, WA 99350 Phone: 509-786-6626 |
Evan Malcom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Chardonnay Ave, Prosser, WA 99350 Phone: 509-786-2222 |
Cameron Rose Holt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 832 Park Ave, Prosser, WA 99350 Phone: 509-786-2020 |
Emmalee Mason, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576 |
Cortney Jean White Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Chardonnay Ave, Prosser, WA 99350 Phone: 509-786-6626 |
Mrs. Nicole Deanne Denny, MA, CCC-SLP, L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Chardonnay Blvd, Prosser Physical Therapy And Rehab, Prosser, WA 99350 Phone: 509-786-6626 |
Mrs. Audrey Carlson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 326 Chardonnay Ave Ste 1, Prosser, WA 99350 Phone: 509-786-6626 |
Amy M. Larsen, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 723 Memorial St, Prosser, WA 99350 Phone: 509-786-2222 |
Ms. Anne Louise Mochel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 502 Myrtle Ave, Prosser, WA 99350 Phone: 509-781-0639 |
News Archive
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology. The findings contribute to increased understanding about how our immune system responds against COVID-19 infection.
"CHI commends the FDA for its recognition of the need for a more efficient regulatory pathway for innovative medical devices that have the potential to improve lives," said CHI President and CEO David L. Gollaher, Ph.D. "It is essential that the FDA maintains focus on initiatives that strengthen the medical device review process, bringing greater clarity and consistency, while ensuring the U.S. maintains its competitive edge."
Are abnormal intestinal microorganisms a risk factor for developing cognitive impairment? Researchers at Rush University Medical Center are trying to answer that question with a new study that will explore how the intestinal microbiota – the bacteria in the intestine –influence the progression of cognitive decline and the development of Alzheimer's disease.
Making colonoscopy available at no cost to eligible Medicare beneficiaries under the Affordable Care Act did not increase the number of people in this target population who regularly undergo the procedure, says a new large scale national study from University Hospitals Case Medical Center Seidman Cancer Center.
› Verified 1 days ago